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Summary. Immunochemical analysis of cultured human mela- 
noma cell detergent extracts and spent culture medium with 
conventional xenoantisera and monoclonal antibodies identified 
four types of 94,000 (94K) dalton molecules and two types of 
high-molecular-weight melanoma-associated antigens by the 
following characteristics: (1) association with other compo- 
nents, (2) mobility in SDS-PAGE under reducing and nonre- 
ducing conditions, (3) antigenicity, and (4) presence in spent 
culture medium. Conventional xenoantisera were found to 
contain antibody populations to antigenically distinct structures, 
some of which have similar apparent molecular weights. 
Immunodepletion studies showed that the antigenic determinant 
detected by the monoclonaI antibody 225.28S to a high-mo- 
lecular-weight melanoma-associated antigen was expressed on a 
subpopulation of the antigens defined by the conventional 
xenoantiserum #8995. These data prove that antibodies reactive 
with antigens of similar molecular weight cannot be assumed to 
identify the same structures, and indicate .that tumor-associated 
antigens may be heterogeneous in the expression of antigenic 
determinants defined by monoclonal antibodies. 
Introduction 
A number of tumor-associated antigens have been identified in 
human melanoma cells with both conventional xenoantisera 
[for review, see 8] and monoclonal antibodies [4, 5, 10, 12, 13, 
20, 22-24]. In many cases antigens of similar molecular weight 
and subunit structure have been described. Thus, Dippold et 
al. [5], Woodbury et al. [23], and Wilson et al. [22], using 
monoclonal antibodies, and Galloway et al. [9], using 
conventional xenoantisera, have described a single chain 
melanoma-associated antigen (MAA) having a molecular 
weight in the range 94,000-97,000 (94K-97K) daltons. Fur- 
thermore, Mitchell et al. [15], using a monoclonal antibody 
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have described a 95K dalton MAA, which is associated with 
three additional components having molecular weights of 
116K, 29K, and 26K daltons, while Wilson et al. [20, 22], also 
using a monoclonal antibody, have identified a 94K dalton 
glycopolypeptide which is associated with 75K, 70K, and 25K 
dalton structures. Also, Galloway et al. [9], using conventional 
xenoantisera, described a 240K dalton spent medium MAA 
and, more recently, we characterized monoclonal antibodies 
immunoprecipitating a similar molecular weight glycopolypep- 
tide from cultured melanoma cells [16, 20]. Whether these 
various antibodies are recognizing the same or different 
antigenic structures and whether a determinant defined by a 
monoclonal antibody is expressed on all the molecules 
comprising a given type of MAA are areas of investigation 
critical to future progress in the field of tumor-associated 
antigens. The need for this information is felt among 
investigators in the melanoma field, as indicated by the 
organization of workshops to exchange monoclonal antibodies 
and compare their specificity and by a recent paper by Brown 
et al. [3] who, through immunodepletion experiments, have 
shown that the 97K dalton glycoprotein recognized by their 
antibody is identical to the 95K dalton glycoprotein identified 
by the monoclonal antibody of Dippold et al. [5]. 
In this paper we have addressed ourselves to these 
problems by using xenoantisera and monoclonal antibodies to 
determine the antigenic relationship among structures with a 
similar apparent molecular weight and we have assessed 
whether the determinants identified by the monoclonal 
antibodies are expressed by all the molecules of a given type of 
MAA. We have focused on 94K dalton and high-molecu- 
lar-weight antigens synthesized by cultured melanoma cells, 
since the former has been described in several reports and the 
latter appears to be restricted to melanoma [16, 20, 22]. 
Materials and Methods 
Cultured Human Cell Lines. Human cells in long-term culture 
were maintained in RPMI 1640 medium containing 10% calf 
serum. The growth characteristics and the histocompatibility 
antigenic profiles of the various cells used are reported 
elsewhere [20]. A confluent monolayer of melanoma cells 
(BwV) in a T-25 flask (Falcon Plastics, Cockeysville, MD) was 
intrinsically radiolabelled with 2 mCi 3H-glucosamine 
D-[6-3H(N)], 30 mCi/mMole (New England Nuclear, Boston, 
MA) according to the method described by Duksin and 
Bornstein [6]. The medium was removed and the monolayer 
was extensively washed with phosphate-buffered saline (PBS) 
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before addition of 2 ml 0.5% Nonidet P-40 (NP-40) detergent 
in PBS containing 10 ~M of the proteolytic inhibitor, 
phenylmethylsulfonylfiuoride. The resulting extract was 
cleared by centrifugation at 7,000 g and stored at -20  ° C. 
Conventional Antisera. Antiserum #8986 was from a rabbit 
immunized with somatic cell hybrids derived from the fusion of 
human melanoma cells with murine fibroblasts [11]; following 
absorption with cultured lymphoid cells this xenoantiserum 
reacted with both melanoma and carcinoma cells in binding 
assays. The xenoantiserum #8995 to a high molecular weight 
MAA was produced by weekly injections of a 3 M KC1 extract 
from cultured human melanoma cells (M21) which had been 
bound to lentil lectin Sepharose [9]; following absorption with 
cultured lymphoid cells this xenoantiserum reacts with mela- 
noma cells but does not react with carcinoma cells. The 
xenoantiserum #8823 was from a rabbit immunized with 
human Ia-like antigens bound to an immunoadsorbent formed 
by reacting an NP40 extract of cultured B lymphoid cells Raji 
with Staphylococcus aureus Cowan I strain bacteria loaded 
with antibodies from a rabbit anti-Daudi cell xenoantiserum; 
the antiserum had been absorbed with cultured human T cells 
(Molt-4) prior to reaction with the bacteria [19]. This 
xenoantiserum (#8823) specifically reacted with Ia-like anti- 
gen-beating cells in serological assays. A xenoantiserum to 
human plasma fibronectin was prepared according to the 
method of Engvall and Ruoslahti [7]. 
MonoclonaI Antibodies (MoAb). The MoAbs 225.28S, 
376.96S, and 465.12S, all IgG2a, were secreted by hybridomas 
constructed with the murine myeloma cells Sp 2/0-Ag 14 and 
splenocytes from BALB/c mice immunized with cultured 
human melanoma cells. Each hybridoma has been subcloned 
at least twice and has been propagated in vitro and in vivo. The 
MoAb 225.28S specifically reacts with nevi, melanoma, and 
some skin cell carcinomas, while the MoAb 376.96S reacts with 
both melanomas and various carcinomas [20, 22]. The MoAb 
465.12S identifies an antigen present in the cytoplasm of a large 
variety of normal and malignant cells [20, 22]. The method of 
preparation and the serological and immunochemical charac- 
terization of the specificity of each monoclonal antibody have 
been described elsewhere [12, 16, 20, 22]. 
Indirect Immunoprecipitation and Sodium DodecyI Sulfate 
Polyacrylamide Gel EIectrophoresis (SDS-PAGE). Indirect 
immunoprecipitation was performed as described previously 
[1], except that protein A-Sepharose-4B was used in place of 
formalin-fixed bacteria, and pre-clearing of the NP-40 deter- 
gent cell extract was not necessary. For immunodepletion 
experiments, a 3H-glucosamine-labelled antigen preparation 
(300 ~tl) was reacted three successive times for 2 h at 4 ° C with 
30 ~tl protein A-Sepharose 4B coupled with either normal IgG 
(negative control depletion) or xenoantibodies. The remaining 
unreactive antigens were then separated into equal aliquots 
and tested for reactivity with the same antibody as was used for 
depletion (to insure its completeness) and with other anti- 
bodies of interest. 
SDS-PAGE was performed in 80 x 1.5 mrn slab gels 
containing 7.5% polyacrylamide and the SDS buffer system of 
Laemmli [14]. The gels containing 3H-glucosamine-labelled 
antigens were processed for fluorography as described by 
Bonner and Laskey [2]. Human plasma fibronectin (220K), 
rabbit phosporylase a (94,000), bovine serum albumin 
(68,000), ovalbumin (44,000), carbonic anhydrase (29,000), 
and whale myoglobin (17,000) were used as molecular weight 
standards. 
Results 
Identification of a Family 
of AntigenicaUy Distinct 94K Dalton Molecules Synthesized 
and Shed by Melanoma Cells 
The MoAb 376.96S, 465.12S and the polyclonal xenoantisera 
#8823 and #8986 all immunoprecipitated structures which 
when electrophoresed under reducing conditions gave appar- 
ent molecular weights of 94K (Fig. 1). That these 94K dalton 
structures may be different is suggested by the fact that the 
MoAb 465.12S immunoprecipitates a 75K, a 70K, and a 25K 
dalton structure in addition to the 94K dalton molecule, and 
the 94K dalton molecule detected by MoAb 376.96S exhibits a 
much broader molecular weight heterogeneity than does the 
94K dalton molecules identified by the other antibody 
reagents. Furthermore, SDS-PAGE under nonreducing con- 
ditions showed that the 94K dalton molecules detected by the 
xenoantiserum #8823 exhibited a decrease in apparent 
molecular weight to 82K daltons (Fig. 1), while the structures 
identified by MoAbs 465.12S, 376.96S and xenoantiserum 
#8986 showed a decrease in apparent molecular weight to 86K 
daltons. Interestingly, the 94K dalton structure identified by 
xenoantiserum #8986 resolves into two molecules under 
nonreducing conditions, one being similar to the type detected 
by the xenoantiserum #8823 and the other to the type detected 
by the MoAb 465.12S. This latter conclusion is consistent with 
the small amounts of the 75K and 70K dalton components 
immunoprecipitated by the xenoantiserum #8986. Additional 
evidence that melanoma cells synthesize three different 94K 
dalton molecules was obtained from sequential immunode- 
pletion studies. A 3H-glucosamine-labelled NP40 melanoma 
Fig. 1. SDS-PAGE analysis of human melanoma cell-derived 94K 
dalton molecules defined by monoclonal antibodies and conventional 
xenoantisera. A 3H-glucosamine-labelled BwV melanoma cell NP40 
extract was immunoprecipitated with antibodies bound to Sepharose 
4B, after which the eluted antigens were boiled in the presence or 
absence of 2-mercaptoethanol and then subjected to SDS-PAGE 
cell extract exhaustively depleted of all the 94K dalton 
molecules reactive with the MoAb 465.12S still contained the 
94K dalton molecules detected with Mc,Ab 376.96S and with 
xenoantisera #8823 and #8986 (Fig. 2); conversely, depletion 
of a similar radiolabelled melanoma cell extract with the 
MoAb 376.96S did not effect the 94K dalton structures 
detectable by MoAb 465.12S and by the xenoantiserum #8823 
and #8986 (data not shown). The xenoantisera were not used 
for immunodepleting the labelled cell extracts, since these 
reagents are only operationally specific and may contain small 
amounts of antibodies to all the various 94K dalton molecules, 
resulting in a false interpretation of antigenic similarity. 
Immunoprecipitation of the 3H-glucosamine-labelled 
spent culture medium from melanoma cells with the various 
antibodies to the 94K dalton structures was performed to 
determine whether these structures are shed by melanoma cells 
(Fig. 3). The MoAb 376.96S occasionally detected a small 
amount of 94K component in the spent medium of cultured 
melanoma cells, the xenoantiserum #8823 reacted with 
fibronectin while the MoAb 465.12 and the xenoantiserum 
#8986 immunoprecipitated a major 94K and a minor 72K 
dalton structure. Immunodepletion experiments showed that 
the MoAb 465.12 and the xenoantiserum #8986 each reacts 
with the same population of 94K dalton molecules present in 
the spent medium of 3H-glucosamine-labelled melanoma cells 
(Fig. 4). It should be noted that the minor 72K dalton structure 
detected by MoAb 465.12S and xenoantiserum #8986 is not 
easily identified in some melanoma cell lines, such as Colo 38 
and M21. Furthermore, examination of unfractioned 3H-glu- 
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cosamine spent media under reducing and nonreducing 
conditions revealed a fourth 94K dalton structure previously 
undetected (Fig. 3), which exhibits an increased apparent 
molecular weight under nonreducing conditions, suggesting 
that in its native state it is disulfde-linked to a small-molec- 
ular-weight polypeptide. 
Identification of Antigenically Distinct 
High-Molecular-Weight Melanoma-Associated 
Antigens Synthesized and Shed by Melanoma Cells 
The monoclonal antibodies 225.28S and the xenoantiserum 
#8995 both immunoprecipitate two components from 3H-glu- 
cosamine-labelled melanoma cells BwV (Fig. 5). One com- 
ponent at 280K daltons exhibits a slightly higher apparent 
molecular weight than melanoma BwV fibronectin, while the 
other structure is very large and can barely penetrate the top of 
the gel. The molecular weight of the latter component will be 
referred to as > 440K daltons (nonreduced human plasma 
fibronectin) until appropriate molecular weight determinations 
can be done. The MoAb 225.28S is unable to bind all the 280K 
and > 440K dalton molecules reacting with the xenoantisera 
#8995, since the latter can still immunoprecipitate the 
high-molecular-weight structures from a cell extract com- 
pletely depleted of such molecules reactive with the mono- 
clonal antibody (Fig. 6). These data indicate that the antigenic 
determinant detected by the MoAb 225.28S is not present on 
all the molecules comprising the 280K and > 440K dalton 
high-molecular-weight MAA system. 
Fig. 2. Sequential immunodepletion analysis of 94K dalton molecules 
synthesized by melanoma cells. A 3H-glucosamine-labelled BwV 
melanoma cell NP40 extract was exhaustively immunodepleted with 
normal human IgG Sepharose 4B or Sepharose 4B loaded with MoAb 
465.12S. The supernatant was immunoprecipil~ated with xenoantibod- 
ies and then subjected to SDS-PAGE under reducing conditions (2% 
2-mercaptoethanol) 
Fig. 3. SDS-PAGE analysis of 94K dalton molecules shed by cultured 
human melanoma ceils. Spent culture medium from 3H-glucosam- 
ine-labelled BwV melanoma cells was immunoprecipitated with 
xenoantibodies, after which the eluted antigens were boiled in the 
presence or absence of 2-mercaptoethanol and then analyzed by 
SDS-PAGE. Unfractionated 3H-glucosamine spent culture medium 
was from BwV melanoma ceils. 
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When spent medium of 3H-glucosamine-labelled cultured 
melanoma cells is used as an antigen source, the MoAb 
225.28S reacts with a very large structure seen at the top of the 
gel (>  440K), while the xenoantiserum #8995 reacts with a 
component of approximately 300K daltons (Fig. 5). Even 
though the xenoantiserum detects the same high-molec- 
ular-weight cellular antigen identified by the monoclonal 
antibody, a > 440K dalton molecule was not immunopreci- 
pirated from the spent culture medium by xenoantiserum 
#8995, because the amount of labelled antigens used and the 
exposure time in fluorography were not sufficient to detect this 
component. Althouth we have been unable to repeat this 
experiment with the appropriate conditions because the 
xenoantiserum #8995 is now unavailable, we have seen that 
other xenoantisera which immunoprecipitate the 280K and 
> 440K dalton cellular structures will also identify the > 440K 
dalton media molecule under the appropriate conditions. 
Fig. 4. Distribution of the antigenic determinant detected by MoAb 
465.12S on 94K dalton molecules detected with the xenoantiserum 
#8986. A 3H-glucosamine-labelled preparation of BwV melanoma 
spent culture medium was exhaustively immunodepleted by sequential 
reactions with normal human IgG Sepharose 4B or xenoantibodies 
bound to Sepharose 4B. The remaining labelled antigens were 
immunoprecipitated by xenoantibodies bound to Sepharose 4B, and 
then subjected to SDS-PAGE under reducing conditions 
Fig. 6. Distribution of the antigenic determinant detected by MoAb 
225.28S on the high-molecular-weight antigens detected by xenoan- 
tiserum #8995. A 3H-glucosamine-labelled BwV melanoma cell NP40 
extract was exhaustively immunodepleted by sequential reaction with 
normal human IgG Sepharose 4B or xenoantibodies bound to 
Sepharose 4B. The remaining labelled antigens were irnmunopreci- 
pirated by xenoantibodies bound to Sepharose 4B and then subjected 
to SDS-PAGE under reducing conditions 
- ~  Fig. 5. SDS-PAGE analysis with the monoclonal antibody 225.28S and 
with the conventional xenoantiserum #8985 of high-molecular-weight 
MAA synthesized and shed by melanoma cells. An NP40 extract (first 
and second lane from the left) or the spent culture medium (third, 
fourth and fifth lane) of 3H-glucosamine-labelled BwV melanoma ceils 
was immunoprecipitated with the insolubilized xenoantibodies, after 
which the eluted antigens were boiled in the presence of 2-mercap- 
toethanol and analyzed by SDS-PAGE 
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Discussion 
Immunochemical analysis of human melanoma cells with 
conventional xenoantisera and monoclonal xenoantibodies has 
identified several antigenically distinct structures that have 
similar apparent molecular weights. Four types of 94K dalton 
molecules and two types of high-molecular-weight antigens 
were identified by the following characteristics: (1) association 
with other components, (2) mobility in SDS-PAGE under 
reducing and nonreducing conditions, (3) antigenicity, and (4) 
presence in spent culture media. The lVloAb 376.96S reacts 
with a single 94K dalton molecule present on the plasma 
membrane and inconsistently found in spent media, while the 
MoAb 465.12 and the xenoantiserum #8986 immunoprecipi- 
tate cellular 75K, 70K, and 25K dalton components in addition 
to a major 94K dalton and a minor 72K dalton structure which 
are readily shed into spent culture medium. Immunodepletion 
studies showed that the spent media 94K dalton molecule 
detected by MoAb 465.12S is the same structure as was 
identified with conventional xenoantisera and already 
described in a previous study [9]. The spent media 72K dalton 
molecule was not identified in the previous study since it is 
readily detectable in media from only some melanoma cell 
lines, which were not included in the earlier study. The 
xenoantiserum #8823 reacts with a cellular 94K dalton 
molecule distinct from the ones detected by our monoclonal 
antibodies, while a fourth 94K dalton molecule was detected in 
spent culture medium and was probably disulfide-bridged in its 
native state with a small-molecular-weight protein. We 
presently have no antibodies reactive with this 94K dalton 
media molecule. 
In regard to high-molecular-weight antigens, the MoAb 
225.28S and the xenoantiserum #8995 recognize two glyco- 
sylated structures from detergent extracts of cultured mela- 
noma cells, one at 280K daltons and the other > 440K daltons, 
while only the > 440K dalton structure was detectable in the 
spent culture medium. In addition, the xenoantiserum #8995 
detects a 300K dalton molecule present in spent culture 
medium but not in labelled cell extracts. The latter structure is 
either not solubilized by treatment with nonionic detergent 
(NP40) or is rapidly transported outside the cells and into the 
medium following synthesis. The media molecule detected by 
xenoantiserum #8995 was previously estimated to be 240K [9] 
rather than 300K daltons, since melanoma-derived fibronectin 
used as a molecular weight standard was assumed to have the 
same apparent molecular weight as plasma fibronectin. We 
have recently found that melanoma-derived fibronectin has a 
40K dalton greater apparent molecular weight than plasma 
fibronectin [21], hence increasing the molecular weight 
estimation of the spent medium MAA  from 240K daltons to 
approximately 300K daltons. 
The comparison of conventional xenoantisera with mon- 
oclonal antibodies clearly illustrates the limitations inherent in 
the former reagent. The conventional xenoantisera, being only 
operationally monospecific, may contain antibodies to more 
than a single antigenic system and this can be very misleading 
since there are several types of distinct antigenic structures 
having very similar apparent molecular weights. Thus, in the 
case of the xenoantiserum #8995, its reactivity with a 280K 
dalton cellular antigen and a 300K dalton media molecule 
suggested that these structures were antigenically related 
rather than coincidently identified by two different types of 
antibodies in this antiserum; however, the results with 
monoclonal antibodies clearly show that the xenoantiserum 
contains two different types of antibodies. Another problem is 
that the specificity of xenoantisera may vary from bleeding to 
bleeding, resulting in limited supplies of a particular reagent. 
In fact, we have exhausted our supply of several xenoantisera, 
including #8995, and have tried unsuccessfully to produce 
other reagents with similar specificities. 
When we assessed the distribution of antigenic determi- 
nants detectable by monoclonal antibodies in the population of 
antigens defined with a conventional xenoantiserum, we found 
that the determinant detected by MoAb 465.12S was present 
on all the 94K dalton molecules, while the determinant defined 
by MoAb 225.28S is detectable on only a subpopulation of the 
high-molecular-weight antigens. Therefore, the family of 
> 440K/280K dalton molecules is heterogeneous in the 
expression of determinants defined by monoclonal antibodies. 
These results parallel our previous experiences with mono- 
clonal antibodies to HLA-A,B,C and human h-like antigens 
[17, 18], suggesting that the high-molecular-weight MAA may 
be polymorphic. It will be interesting to determine whether the 
molecules carrying antigenic determinants detected by the 
monoclonal antibodies to the high-molecular-weight M A A  are 
expressed on all the cells of a melanoma population and 
whether expression of a particular antigenic determinant is 
associated with a certain clinical course of this disease. 
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